Products billed under this code include Methylprednisolone Sodium Succ, Methylprednisolone Sodium Succinate, Solu-Medrol.
Payment limit per 5 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Methylprednisolone Sodium Succ | Hikma Pharmaceuticals USA Inc. | 00143-9753-25 | 200 | $51.00 |
| Methylprednisolone Sodium Succ | Hikma Pharmaceuticals USA Inc. | 00143-9754-25 | 625 | $159.375 |
| Methylprednisolone Sodium Succ | Hikma Pharmaceuticals USA Inc. | 00143-9850-01 | 100 | $25.50 |
| Methylprednisolone Sodium Succ | Hikma Pharmaceuticals USA Inc. | 00143-9851-01 | 200 | $51.00 |
| Methylprednisolone Sodium Succ | Dr. Reddy's Laboratories Inc. | 43598-0127-25 | 200 | $51.00 |
| Methylprednisolone Sodium Succ | Dr. Reddy's Laboratories Inc. | 43598-0128-11 | 100 | $25.50 |
| Methylprednisolone Sodium Succ | Dr. Reddy's Laboratories Inc. | 43598-0129-25 | 625 | $159.375 |
| Methylprednisolone Sodium Succ | Dr. Reddy's Laboratories Inc. | 43598-0130-74 | 200 | $51.00 |
| Methylprednisolone Sodium Succ | FreseniUS Kabi USA, LLC | 63323-0255-03 | 200 | $51.00 |
| Methylprednisolone Sodium Succ | FreseniUS Kabi USA, LLC | 63323-0258-03 | 625 | $159.375 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Methylprednisolone Sodium Succ | FreseniUS Kabi USA, LLC | 63323-0265-30 | 200 | $51.00 |
| Methylprednisolone Sodium Succinate | Civica, Inc. | 72572-0097-25 | 200 | $51.00 |
| Methylprednisolone Sodium Succinate | Civica, Inc. | 72572-0098-25 | 625 | $159.375 |
| Solu-Medrol | Pfizer Inc | 00009-0003-02 | 100 | $25.50 |
| Solu-Medrol | Pfizer Inc | 00009-0018-20 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0039-06 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0039-28 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0039-32 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0047-04 | 625 | $159.375 |
| Solu-Medrol | Pfizer Inc | 00009-0047-22 | 625 | $159.375 |
| Solu-Medrol | Pfizer Inc | 00009-0047-26 | 625 | $159.375 |
| Solu-Medrol | Pfizer Inc | 00009-0698-01 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0698-02 | 200 | $51.00 |
| Solu-Medrol | Pfizer Inc | 00009-0758-01 | 100 | $25.50 |
| Solu-Medrol | Pfizer Inc | 00009-0850-01 | 400 | $102.00 |
| Solu-Medrol | Henry Schein Inc. | 00404-9957-02 | 25 | $6.375 |
| Solu-Medrol | Henry Schein Inc. | 00404-9958-01 | 8 | $2.04 |
| Solu-Medrol | A-S Medication Solutions | 50090-0271-00 | 25 | $6.375 |
| Solu-Medrol | A-S Medication Solutions | 50090-0271-01 | 625 | $159.375 |
| Solu-Medrol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1263-01 | 25 | $6.375 |
| Solu-Medrol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1263-03 | 625 | $159.375 |
| Solu-Medrol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1264-01 | 8 | $2.04 |
| Solu-Medrol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1264-03 | 200 | $51.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.255 | +$0.031 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted September 17, 2026 |
| 3Q26 | $0.224 | −$0.017 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted September 15, 2026 |
| 2Q26 | $0.241 | −$0.023 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted September 15, 2026 |
| 1Q26 | $0.264 | +$0.054 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted September 15, 2026 |
| 4Q25 | $0.21 | −$0.049 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted September 8, 2026 |
| 3Q25 | $0.259 | +$0.008 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted March 10, 2026 |
| 2Q25 | $0.251 | −$0.017 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted March 10, 2026 |
| 1Q25 | $0.268 | −$0.036 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted December 19, 2025 |
| 4Q24 | $0.304 | +$0.009 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted June 11, 2025 |
| 3Q24 | $0.295 | +$0.022 | 5 MG | Inj, methylpred sod succ 5mg | v1, posted June 11, 2025 |
| 2Q24 | $0.273 | – | 5 MG | Inj, methylpred sod succ 5mg | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
